Equity Overview
Price & Market Data
Price: $0.85
Daily Change: -$0.45 / 52.92%
Range: $0.84 - $1.32
Market Cap: $13,664,328
Volume: 846,195
Performance Metrics
1 Week: -51.61%
1 Month: -55.66%
3 Months: -64.74%
6 Months: -72.97%
1 Year: -76.92%
YTD: -48.86%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.